{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:36:04Z","timestamp":1790433364264,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Irritable bowel syndrome (IBS) is a heterogenic, functional gastrointestinal disorder of the gut-brain axis characterized by altered bowel habit and abdominal pain. Preclinical and clinical results suggested that, in part of these patients, pain may result from fungal induced release of mast cell derived histamine, subsequent activation of sensory afferent expressed histamine-1 receptors and related sensitization of the nociceptive transient reporter potential channel V1 (TRPV1)-ion channel. TRPV1 gating properties are regulated in lipid rafts. Miltefosine, an approved drug for the treatment of visceral Leishmaniasis, has fungicidal effects and is a known lipid raft modulator. We anticipated that miltefosine may act on different mechanistic levels of fungal-induced abdominal pain and may be repurposed to IBS. In the IBS-like rat model of maternal separation we assessed the visceromotor response to colonic distension as indirect readout for abdominal pain. Miltefosine reversed post-stress hypersensitivity to distension (i.e. visceral hypersensitivity) and this was associated with differences in the fungal microbiome (i.e. mycobiome).\n                    <jats:italic>In vitro<\/jats:italic>\n                    investigations confirmed fungicidal effects of miltefosine. In addition, miltefosine reduced the effect of TRPV1 activation in TRPV1-transfected cells and prevented TRPV1-dependent visceral hypersensitivity induced by intracolonic-capsaicin in rat. Miltefosine may be an attractive drug to treat abdominal pain in IBS.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-49096-y","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T06:03:26Z","timestamp":1567058606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms"],"prefix":"10.1038","volume":"9","author":[{"given":"Sara","family":"Botschuijver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie A.","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-9048","authenticated-orcid":false,"given":"Isabelle A. M.","family":"van Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael S.","family":"Saia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Strik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhumei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7992-510X","authenticated-orcid":false,"given":"Daniele","family":"Maria-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Welting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Keszthelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid E. M.","family":"Heinsbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1779-0833","authenticated-orcid":false,"given":"Ronald P. Oude","family":"Elferink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6982-5340","authenticated-orcid":false,"given":"Frank H. J.","family":"Schuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter J.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 M.","family":"van den Wijngaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"49096_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/MCG.0b013e318189a7f9","volume":"43","author":"DA Drossman","year":"2009","unstructured":"Drossman, D. A. et al. International Survey of Patients With IBS Symptom Features and Their Severity, Health Status, Treatments, and Risk Taking to Achieve Clinical Benefit. Journal of clinical gastroenterology 43, 541\u2013550, https:\/\/doi.org\/10.1097\/MCG.0b013e318189a7f9 (2009).","journal-title":"Journal of clinical gastroenterology"},{"key":"49096_CR2","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1038\/533S116a","volume":"533","author":"B Morgan","year":"2016","unstructured":"Morgan, B. Drug development: A healthy pipeline. Nature 533, S116\u2013117, https:\/\/doi.org\/10.1038\/533S116a (2016).","journal-title":"Nature"},{"key":"49096_CR3","doi-asserted-by":"publisher","first-page":"G141","DOI":"10.1152\/ajpgi.00060.2012","volume":"303","author":"D Keszthelyi","year":"2012","unstructured":"Keszthelyi, D., Troost, F. J. & Masclee, A. A. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. American journal of physiology. Gastrointestinal and liver physiology 303, G141\u2013154, https:\/\/doi.org\/10.1152\/ajpgi.00060.2012 (2012).","journal-title":"American journal of physiology. Gastrointestinal and liver physiology"},{"key":"49096_CR4","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1053\/j.gastro.2017.06.004","volume":"153","author":"S Botschuijver","year":"2017","unstructured":"Botschuijver, S. et al. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats. Gastroenterology 153, 1026\u20131039, https:\/\/doi.org\/10.1053\/j.gastro.2017.06.004 (2017).","journal-title":"Gastroenterology"},{"key":"49096_CR5","doi-asserted-by":"publisher","first-page":"e66884","DOI":"10.1371\/journal.pone.0066884","volume":"8","author":"OI Stanisor","year":"2013","unstructured":"Stanisor, O. I. et al. Stress-induced visceral hypersensitivity in maternally separated rats can be reversed by peripherally restricted histamine-1-receptor antagonists. PloS one 8, e66884, https:\/\/doi.org\/10.1371\/journal.pone.0066884 (2013).","journal-title":"PloS one"},{"key":"49096_CR6","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1365-2982.2009.01339.x","volume":"21","author":"RM van den Wijngaard","year":"2009","unstructured":"van den Wijngaard, R. M. et al. Essential role for TRPV1 in stress-induced (mast cell-dependent) colonic hypersensitivity in maternally separated rats. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society 21, 1107\u2013e1194, https:\/\/doi.org\/10.1111\/j.1365-2982.2009.01339.x (2009).","journal-title":"Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society"},{"key":"49096_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","volume":"126","author":"G Barbara","year":"2004","unstructured":"Barbara, G. et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126, 693\u2013702, https:\/\/doi.org\/10.1053\/j.gastro.2003.11.055 (2004).","journal-title":"Gastroenterology"},{"key":"49096_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2006.11.039","volume":"132","author":"G Barbara","year":"2007","unstructured":"Barbara, G. et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132, 26\u201337, https:\/\/doi.org\/10.1053\/j.gastro.2006.11.039 (2007).","journal-title":"Gastroenterology"},{"key":"49096_CR9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/gut.2010.213108","volume":"59","author":"TK Klooker","year":"2010","unstructured":"Klooker, T. K. et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 59, 1213\u20131221, https:\/\/doi.org\/10.1136\/gut.2010.213108 (2010).","journal-title":"Gut"},{"key":"49096_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/j.gastro.2015.12.034","volume":"150","author":"MM Wouters","year":"2016","unstructured":"Wouters, M. M. et al. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome. Gastroenterology 150, 875\u2013887 e879, https:\/\/doi.org\/10.1053\/j.gastro.2015.12.034 (2016).","journal-title":"Gastroenterology"},{"key":"49096_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40263-013-0128-0","volume":"28","author":"LF Bastos","year":"2014","unstructured":"Bastos, L. F. & Coelho, M. M. Drug repositioning: playing dirty to kill pain. CNS drugs 28, 45\u201361, https:\/\/doi.org\/10.1007\/s40263-013-0128-0 (2014).","journal-title":"CNS drugs"},{"key":"49096_CR12","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/jac\/dks275","volume":"67","author":"TP Dorlo","year":"2012","unstructured":"Dorlo, T. P., Balasegaram, M., Beijnen, J. H. & de Vries, P. J. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother 67, 2576\u20132597, https:\/\/doi.org\/10.1093\/jac\/dks275 (2012).","journal-title":"J Antimicrob Chemother"},{"key":"49096_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bbalip.2012.10.008","volume":"1831","author":"WJ van Blitterswijk","year":"2013","unstructured":"van Blitterswijk, W. J. & Verheij, M. Anticancer mechanisms and clinical application of alkylphospholipids. Biochim Biophys Acta 1831, 663\u2013674, https:\/\/doi.org\/10.1016\/j.bbalip.2012.10.008 (2013).","journal-title":"Biochim Biophys Acta"},{"key":"49096_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.fgb.2014.04.003","volume":"67","author":"C Biswas","year":"2014","unstructured":"Biswas, C. et al. Functional disruption of yeast metacaspase, Mca1, leads to miltefosine resistance and inability to mediate miltefosine-induced apoptotic effects. Fungal genetics and biology: FG & B 67, 71\u201381, https:\/\/doi.org\/10.1016\/j.fgb.2014.04.003 (2014).","journal-title":"Fungal genetics and biology: FG & B"},{"key":"49096_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/AAC.50.2.414-421.2006","volume":"50","author":"F Widmer","year":"2006","unstructured":"Widmer, F. et al. Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis. Antimicrob Agents Chemother 50, 414\u2013421, https:\/\/doi.org\/10.1128\/AAC.50.2.414-421.2006 (2006).","journal-title":"Antimicrob Agents Chemother"},{"key":"49096_CR16","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1111\/j.1468-3083.2012.04689.x","volume":"27","author":"M Magerl","year":"2013","unstructured":"Magerl, M. et al. Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology: JEADV 27, e363\u2013369, https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04689.x (2013).","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"key":"49096_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/09546634.2012.671909","volume":"24","author":"M Maurer","year":"2013","unstructured":"Maurer, M., Magerl, M., Metz, M., Weller, K. & Siebenhaar, F. Miltefosine: a novel treatment option for mast cell-mediated diseases. The Journal of dermatological treatment 24, 244\u2013249, https:\/\/doi.org\/10.3109\/09546634.2012.671909 (2013).","journal-title":"The Journal of dermatological treatment"},{"key":"49096_CR18","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3389\/fimmu.2018.01563","volume":"9","author":"Z Rubikova","year":"2018","unstructured":"Rubikova, Z., Sulimenko, V., Paulenda, T. & Draber, P. Mast Cell Activation and Microtubule Organization Are Modulated by Miltefosine Through Protein Kinase C Inhibition. Frontiers in immunology 9, 1563, https:\/\/doi.org\/10.3389\/fimmu.2018.01563 (2018).","journal-title":"Frontiers in immunology"},{"key":"49096_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/jid.2008.248","volume":"129","author":"K Weller","year":"2009","unstructured":"Weller, K. et al. Miltefosine Inhibits Human Mast Cell Activation and Mediator Release Both In Vitro and In Vivo. Journal of Investigative Dermatology 129, 496\u2013498, https:\/\/doi.org\/10.1038\/jid.2008.248 (2009).","journal-title":"Journal of Investigative Dermatology"},{"key":"49096_CR20","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.febslet.2006.03.079","volume":"580","author":"B Heczkova","year":"2006","unstructured":"Heczkova, B. & Slotte, J. P. Effect of anti-tumor ether lipids on ordered domains in model membranes. FEBS letters 580, 2471\u20132476, https:\/\/doi.org\/10.1016\/j.febslet.2006.03.079 (2006).","journal-title":"FEBS letters"},{"key":"49096_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12617","volume":"149","author":"P Varshney","year":"2016","unstructured":"Varshney, P., Yadav, V. & Saini, N. Lipid rafts in immune signalling: current progress and future perspective. Immunology 149, 13\u201324, https:\/\/doi.org\/10.1111\/imm.12617 (2016).","journal-title":"Immunology"},{"key":"49096_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.phrs.2015.07.028","volume":"100","author":"E Saghy","year":"2015","unstructured":"Saghy, E. et al. Evidence for the role of lipid rafts and sphingomyelin in Ca2+-gating of Transient Receptor Potential channels in trigeminal sensory neurons and peripheral nerve terminals. Pharmacological research 100, 101\u2013116, https:\/\/doi.org\/10.1016\/j.phrs.2015.07.028 (2015).","journal-title":"Pharmacological research"},{"key":"49096_CR23","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1128\/AAC.01428-06","volume":"51","author":"D Llull","year":"2007","unstructured":"Llull, D., Rivas, L. & Garcia, E. In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci. Antimicrob Agents Chemother 51, 1844\u20131848, https:\/\/doi.org\/10.1128\/AAC.01428-06 (2007).","journal-title":"Antimicrob Agents Chemother"},{"key":"49096_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1365-2982.2009.01287.x","volume":"21","author":"RM van den Wijngaard","year":"2009","unstructured":"van den Wijngaard, R. M. et al. Possible role for TRPV1 in neomycin-induced inhibition of visceral hypersensitivity in rat. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society 21, 863\u2013e860, https:\/\/doi.org\/10.1111\/j.1365-2982.2009.01287.x (2009).","journal-title":"Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society"},{"key":"49096_CR25","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1365-2982.2005.00677.x","volume":"17","author":"O Welting","year":"2005","unstructured":"Welting, O., Van Den Wijngaard, R. M., De Jonge, W. J., Holman, R. & Boeckxstaens, G. E. Assessment of visceral sensitivity using radio telemetry in a rat model of maternal separation. Neurogastroenterol. Motil. 17, 838\u2013845, https:\/\/doi.org\/10.1111\/j.1365-2982.2005.00677.x (2005).","journal-title":"Neurogastroenterol.Motil."},{"key":"49096_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejphar.2009.11.052","volume":"628","author":"E Szoke","year":"2010","unstructured":"Szoke, E. et al. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line. European journal of pharmacology 628, 67\u201374, https:\/\/doi.org\/10.1016\/j.ejphar.2009.11.052 (2010).","journal-title":"European journal of pharmacology"},{"key":"49096_CR27","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1016\/j.bmcl.2006.03.030","volume":"16","author":"HK Rami","year":"2006","unstructured":"Rami, H. K. et al. Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development. Bioorganic & medicinal chemistry letters 16, 3287\u20133291, https:\/\/doi.org\/10.1016\/j.bmcl.2006.03.030 (2006).","journal-title":"Bioorganic & medicinal chemistry letters"},{"key":"49096_CR28","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s11095-006-9170-7","volume":"24","author":"C Menez","year":"2007","unstructured":"Menez, C., Buyse, M., Dugave, C., Farinotti, R. & Barratt, G. Intestinal absorption of miltefosine: contribution of passive paracellular transport. Pharmaceutical research 24, 546\u2013554, https:\/\/doi.org\/10.1007\/s11095-006-9170-7 (2007).","journal-title":"Pharmaceutical research"},{"key":"49096_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/19440049.2011.643458","volume":"29","author":"C Morcia","year":"2012","unstructured":"Morcia, C., Malnati, M. & Terzi, V. In vitro antifungal activity of terpinen-4-ol, eugenol, carvone, 1,8-cineole (eucalyptol) and thymol against mycotoxigenic plant pathogens. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 29, 415\u2013422, https:\/\/doi.org\/10.1080\/19440049.2011.643458 (2012).","journal-title":"Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment"},{"key":"49096_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/molecules14010238","volume":"14","author":"MD Sokovic","year":"2009","unstructured":"Sokovic, M. D. et al. Chemical composition of essential oils of Thymus and Mentha species and their antifungal activities. Molecules (Basel, Switzerland) 14, 238\u2013249, https:\/\/doi.org\/10.3390\/molecules14010238 (2009).","journal-title":"Molecules (Basel, Switzerland)"},{"key":"49096_CR31","doi-asserted-by":"publisher","first-page":"e13299","DOI":"10.1111\/nmo.13299","volume":"30","author":"S Botschuijver","year":"2018","unstructured":"Botschuijver, S. et al. Reversal of visceral hypersensitivity in rat by Menthacarin((R)), a proprietary combination of essential oils from peppermint and caraway, coincides with mycobiome modulation. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society 30, e13299, https:\/\/doi.org\/10.1111\/nmo.13299 (2018).","journal-title":"Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society"},{"issue":"2","key":"49096_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/ijms18020330","volume":"18","author":"Qi Sam","year":"2017","unstructured":"Sam, Q. H., Chang, M. W. & Chai, L. Y. The Fungal Mycobiome and Its Interaction with Gut Bacteria in the Host. International journal of molecular sciences 18, https:\/\/doi.org\/10.3390\/ijms18020330 (2017).","journal-title":"International Journal of Molecular Sciences"},{"key":"49096_CR33","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1113\/jphysiol.2010.191585","volume":"588","author":"C Dart","year":"2010","unstructured":"Dart, C. Lipid microdomains and the regulation of ion channel function. The Journal of physiology 588, 3169\u20133178, https:\/\/doi.org\/10.1113\/jphysiol.2010.191585 (2010).","journal-title":"The Journal of physiology"},{"key":"49096_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrm.2017.16","volume":"18","author":"E Sezgin","year":"2017","unstructured":"Sezgin, E., Levental, I., Mayor, S. & Eggeling, C. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nature reviews. Molecular cell biology 18, 361\u2013374, https:\/\/doi.org\/10.1038\/nrm.2017.16 (2017).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"49096_CR35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","volume":"71","author":"N Robbins","year":"2017","unstructured":"Robbins, N., Caplan, T. & Cowen, L. E. Molecular Evolution of Antifungal Drug Resistance. Annual review of microbiology 71, 753\u2013775, https:\/\/doi.org\/10.1146\/annurev-micro-030117-020345 (2017).","journal-title":"Annual review of microbiology"},{"key":"49096_CR36","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/437942a","volume":"437","author":"S Frantz","year":"2005","unstructured":"Frantz, S. Drug discovery: playing dirty. Nature 437, 942\u2013943, https:\/\/doi.org\/10.1038\/437942a (2005).","journal-title":"Nature"},{"key":"49096_CR37","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/nprot.2007.392","volume":"2","author":"JA Christianson","year":"2007","unstructured":"Christianson, J. A. & Gebhart, G. F. Assessment of colon sensitivity by luminal distension in mice. Nature protocols 2, 2624\u20132631, https:\/\/doi.org\/10.1038\/nprot.2007.392 (2007).","journal-title":"Nature protocols"},{"key":"49096_CR38","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/nmo.12826","volume":"28","author":"SH Park","year":"2016","unstructured":"Park, S. H. et al. Adverse childhood experiences are associated with irritable bowel syndrome and gastrointestinal symptom severity. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society 28, 1252\u20131260, https:\/\/doi.org\/10.1111\/nmo.12826 (2016).","journal-title":"Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society"},{"key":"49096_CR39","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1136\/gut.2003.017962","volume":"53","author":"I Posserud","year":"2004","unstructured":"Posserud, I. et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 53, 1102\u20131108, https:\/\/doi.org\/10.1136\/gut.2003.017962 (2004).","journal-title":"Gut"},{"key":"49096_CR40","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1128\/AEM.03870-12","volume":"79","author":"NA Bokulich","year":"2013","unstructured":"Bokulich, N. A. & Mills, D. A. Improved selection of internal transcribed spacer-specific primers enables quantitative, ultra-high-throughput profiling of fungal communities. Applied and environmental microbiology 79, 2519\u20132526, https:\/\/doi.org\/10.1128\/AEM.03870-12 (2013).","journal-title":"Applied and environmental microbiology"},{"key":"49096_CR41","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","volume":"75","author":"PD Schloss","year":"2009","unstructured":"Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Applied and environmental microbiology 75, 7537\u20137541, https:\/\/doi.org\/10.1128\/AEM.01541-09 (2009).","journal-title":"Applied and environmental microbiology"},{"key":"49096_CR42","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and environmental microbiology 73, 5261\u20135267, https:\/\/doi.org\/10.1128\/AEM.00062-07 (2007).","journal-title":"Applied and environmental microbiology"},{"key":"49096_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1469-8137.2009.03160.x","volume":"186","author":"K Abarenkov","year":"2010","unstructured":"Abarenkov, K. et al. The UNITE database for molecular identification of fungi\u2013recent updates and future perspectives. The New phytologist 186, 281\u2013285, https:\/\/doi.org\/10.1111\/j.1469-8137.2009.03160.x (2010).","journal-title":"The New phytologist"},{"key":"49096_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ygeno.2011.05.009","volume":"98","author":"Y Kong","year":"2011","unstructured":"Kong, Y. Btrim: a fast, lightweight adapter and quality trimming program for next-generation sequencing technologies. Genomics 98, 152\u2013153, https:\/\/doi.org\/10.1016\/j.ygeno.2011.05.009 (2011).","journal-title":"Genomics"},{"key":"49096_CR45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/BF01954148","volume":"15","author":"U Wingren","year":"1983","unstructured":"Wingren, U. & Enerback, L. Mucosal mast cells of the rat intestine: a re-evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan. The Histochemical journal 15, 571\u2013582, https:\/\/doi.org\/10.1007\/BF01954148 (1983).","journal-title":"The Histochemical journal"},{"key":"49096_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1471-4159.2007.04569.x","volume":"102","author":"PM Lam","year":"2007","unstructured":"Lam, P. M. et al. Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca(2+)](i), initiates neurotransmitter release and promotes delayed cell death. Journal of neurochemistry 102, 801\u2013811, https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04569.x (2007).","journal-title":"Journal of neurochemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49096-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:02:29Z","timestamp":1671264149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49096-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49096"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49096-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.J.D.J., received consultancy fees from GlaxoSmithKline and research support from Galvani Bioelectronics, GlaxoSmithKline and Mead Johnsson Nutrition Pediatric Institute. Although G.J. used to be employed by JADO Technologies GmbH, there is no competing interest as the interest (JADO) no longer exists and no successor interests exist either (the discovery of anti-inflammatory effects of miltefosine in mastocytosis, atopic dermatitis and urticaria are in the public domain). All other authors declare no financial competing interests. All authors declare no non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12530"}}